Sutent and confusional state 
Sutent and confusional state Patient Reports February 11, 2012
Sutent Side Effects Report #5633545-7
Sutent side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 09, 2008. Female patient, 65 years of age, weighting 130.1 lb, was diagnosed with uterine leiomyosarcoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: confusional state, dehydration, fatigue, mental status changes. Sutent dosage: unknown. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5596533-5
Sutent side effect was reported by a Consumer or non-health professional from on Jan 07, 2008. Male patient, weighting 252.0 lb, was diagnosed with transitional cell carcinoma, tumour pain and was treated with Sutent. After drug was administered, patient experienced the following side effects: asthenia, confusional state, fatigue, haemoglobin decreased, hallucination. Sutent dosage: unknown. During the same period patient was treated with MS CONTIN, OMEPRAZOLE, LIPITOR, COMPAZINE, ALLOPURINOL, NIFEDIPINE, VICODIN, ASACOL. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5676197-2
Sutent side effect was reported by a Physician from CANADA on Mar 12, 2008. Female patient, 75 years of age, was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: amnesia, confusional state, disorientation, hallucination, auditory, loss of consciousness, palmar-plantar erythrodysaesthesia syndrome, vascular encephalopathy. Sutent dosage: unknown. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5655874-3
Sutent side effect was reported by a Physician from FRANCE on Feb 25, 2008. Female patient, 64 years of age, was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: balance disorder, blood pressure increased, confusional state, dizziness
, hot flush. Sutent dosage: unknown. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #5824946-2
Sutent side effect was reported by a Consumer or non-health professional from FRANCE on July 17, 2008. Female patient, 39 years of age, was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: abdominal pain
, asthenia, blood pressure increased, confusional state, grand mal convulsion, heart rate increased, hemianopia homonymous, hemiplegia, reversible posterior leukoencephalopathy syndrome. Sutent dosage: unknown. Patient recovered.Sutent Side Effects Report #5698139-6
Sutent side effect was reported by a Physician from UNITED STATES on Mar 27, 2008. Female patient, weighting 74.08 lb, was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: blood pressure increased, confusional state, grand mal convulsion, mental status changes, periorbital oedema, reversible posterior leukoencephalopathy syndrome, sinus disorder. Sutent dosage: unknown. During the same period patient was treated with LISINOPRIL, LASIX, ZANTAC, LEVOTHYROXINE, CARDIZEM, CLONIDINE. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5708544-7
Sutent side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 08, 2008. Male patient, weighting 149.9 lb, was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: blood test abnormal, bronchitis
, confusional state, dizziness , dyspnoea, loss of consciousness, skin laceration. Sutent dosage: unknown. During the same period patient was treated with TAMSULOSIN, VITAMINS. Patient recovered.Sutent Side Effects Report #5858526-X
Sutent side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 14, 2008. Male patient, weighting 379.2 lb, was diagnosed with renal cell carcinoma, nausea
, pain and was treated with Sutent. After drug was administered, patient experienced the following side effects: confusional state, dyspnoea, oedema, pyrexia. Sutent dosage: unknown. During the same period patient was treated with COMPAZINE, OXYCONTIN, PERCOCET, NORVASC, AVALIDE, FLOVENT. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #5871084-9
Sutent side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 26, 2008. Male patient, weighting 379.2 lb, was diagnosed with renal cell carcinoma, nausea
, pain and was treated with Sutent. After drug was administered, patient experienced the following side effects: confusional state, dyspnoea, oedema, pyrexia. Sutent dosage: unknown. During the same period patient was treated with COMPAZINE, OXYCONTIN, PERCOCET, NORVASC, AVALIDE, FLOVENT. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #5955705-8
Sutent side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 06, 2008. Male patient, weighting 379.2 lb, was diagnosed with renal cell carcinoma, nausea
, pain and was treated with Sutent. After drug was administered, patient experienced the following side effects: confusional state, dyspnoea, oedema peripheral, pyrexia. Sutent dosage: unknown. During the same period patient was treated with COMPAZINE, OXYCONTIN, PERCOCET, NORVASC, AVALIDE, FLOVENT. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #6058231-3
Sutent side effect was reported by a Physician from ITALY on Jan 18, 2009. Female patient was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: confusional state, encephalitis
, haemangioma, leukopenia, mucosal inflammation, pyrexia, scar , stomatitis, thrombocytopenia. Sutent dosage: 50 MG, 1X/DAY. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #6112684-0
Sutent side effect was reported by a Physician from ITALY on Mar 04, 2009. Female patient was diagnosed with renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: confusional state, encephalitis
, haemangioma, leukopenia, mucosal inflammation, pyrexia, scar , stomatitis, thrombocytopenia. Sutent dosage: 50 MG, 1X/DAY. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #5022528-6
Sutent side effect was reported by a Physician from FRANCE on May 23, 2006. Male patient, 66 years of age, was diagnosed with renal cancer metastatic and was treated with Sutent. After drug was administered, patient experienced the following side effects: asthenia, chills, confusional state, nausea
, pyrexia. Sutent dosage: 50 MG (50 MG, 4 WEEKS INTERVAL 2 WEEKS), ORAL. During the same period patient was treated with COVERSYL, AMLODIPINE, KARDEGIC, TENORMIN, DIAMICRON, GLUCOPHAGE. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #5449364-0
Sutent side effect was reported by a Physician from AUSTRALIA on Aug 30, 2007. Male patient, weighting 121.3 lb, was diagnosed with renal cancer metastatic and was treated with Sutent. After drug was administered, patient experienced the following side effects: acute myocardial infarction, cardiogenic shock, confusional state, depressed level of consciousness, diarrhoea, dyspnoea, hypotension, renal cancer metastatic, vomiting. Sutent dosage: unknown. During the same period patient was treated with WARFARIN, ADALAT, MS CONTIN, TERBINAFINE HYDROCHLORIDE. Patient was hospitalized. Patient died on 07/28/2007.
Sutent Side Effects Report #5939246-X
Sutent side effect was reported by a Physician from UNITED KINGDOM on Oct 22, 2008. Male patient, weighting 189.6 lb, was diagnosed with renal cancer and was treated with Sutent. After drug was administered, patient experienced the following side effects: asthenia, breath sounds abnormal, bronchopneumonia, circulatory collapse, confusional state, dyspnoea, gastrooesophageal reflux disease, incontinence, malaise. Sutent dosage: unknown. During the same period patient was treated with INTERFERON, DEXAMETHASONE. Patient died on 07/22/2008.
Sutent Side Effects Report #6004250-2
Sutent side effect was reported by a Health Professional from UNITED KINGDOM on Dec 04, 2008. Female patient was diagnosed with renal cancer and was treated with Sutent. After drug was administered, patient experienced the following side effects: asthenia, breath sounds abnormal, bronchopneumonia, circulatory collapse, confusional state, disease progression, dyspnoea, gastrooesophageal reflux disease, incontinence. Sutent dosage: unknown. During the same period patient was treated with INTERFERON, DEXAMETHASONE. Patient died on 07/22/2008.
Sutent Side Effects Report #6073585-X
Sutent side effect was reported by a Health Professional from BELGIUM on Jan 30, 2009. Female patient was diagnosed with oesophageal carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: confusional state, disease progression, dyspnoea, pneumonia
, pneumonia aspiration, pulmonary embolism , respiratory failure, somnolence. Sutent dosage: 50 MG, 1X/DAY. During the same period patient was treated with FORLAX, MEDROL, OMEPRAZOLE, DURAGESIC. Patient died on 08/27/2008.Sutent Side Effects Report #5150375-3
Sutent side effect was reported by a Physician from FRANCE on Oct 31, 2006. Male patient, 67 years of age, weighting 163.1 lb, was diagnosed with neoplasm malignant and was treated with Sutent. After drug was administered, patient experienced the following side effects: aphasia
, central nervous system lesion, coma, confusional state, convulsion, dyspnoea, hypotension, nervous system disorder. Sutent dosage: 25 MG (25 MG, 2 WEEKS ON - 1 WEEK OFF), ORAL. During the same period patient was treated with CAMPTOSAR. Patient died on 10/30/2006.Sutent Side Effects Report #5154394-2
Sutent side effect was reported by a Physician from FRANCE on Oct 31, 2006. Male patient, 67 years of age, weighting 163.1 lb, was diagnosed with neoplasm malignant and was treated with Sutent. After drug was administered, patient experienced the following side effects: aphasia
, coma, confusional state, convulsion, dyspnoea, hypotension, nervous system disorder, quadriparesis. Sutent dosage: 25 MG (25 MG, 2 WEEKS ON - 1 WEEK OFF), ORAL. During the same period patient was treated with CAMPTOSAR. Patient died on 10/30/2006.Sutent Side Effects Report #5109495-1
Sutent side effect was reported by a Physician from NETHERLANDS on Sept 04, 2006. Female patient, 84 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: cerebral ischaemia, cerebrovascular accident, cerebrovascular disorder, cognitive disorder, confusional state, gait disturbance. Sutent dosage: unknown. During the same period patient was treated with RISEDRONATE, ACETYLCYSTEINE, OXAZEPAM, METOPROLOL, GABAPENTIN, FUROSEMIDE, PANTOPRAZOLE, OXYCONTIN. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5133245-6
Sutent side effect was reported by a Physician from NETHERLANDS on Oct 05, 2006. Female patient, 84 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: cognitive disorder, confusional state, gait disturbance, ischaemic stroke. Sutent dosage: unknown. During the same period patient was treated with RISEDRONATE, ACETYLCYSTEINE, OXAZEPAM, METOPROLOL TARTRATE, GABAPENTIN, FUROSEMIDE, PANTOPRAZOLE, OXYCONTIN. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5631087-6
Sutent side effect was reported by a Physician from UNITED KINGDOM on Feb 07, 2008. Female patient, 81 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: chills, confusional state, myoclonus, somnolence. Sutent dosage: unknown. During the same period patient was treated with METOCLOPRAMIDE. Patient recovered.
Sutent Side Effects Report #4950402-X
Sutent side effect was reported by a Physician from ITALY on Mar 02, 2006. Female patient, 75 years of age, weighting 149.9 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: anorexia, asthenia, confusional state, hypertension, pyrexia, renal failure. Sutent dosage: 50 MG (50 MG, 1 IN 1 D) ORAL. During the same period patient was treated with LOSARTAN POTASSIUM, MEDROXYPROGESTERONE, OMEPRAZOLE, POLYSTYRENE SULFONATE, ALLOPURINOL, CALCIUM GLUCONATE, FUROSEMIDE, INSULIN RAPID. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5376337-9
Sutent side effect was reported by a Physician from ARGENTINA on June 21, 2007. Male patient, 74 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: confusional state, depression
, fall , mobility decreased, muscular weakness, paraesthesia, sensory loss. Sutent dosage: DAILY DOSE:50MG. During the same period patient was treated with INSULIN, ACETYLSALICYLIC ACID SRT. Patient recovered.Sutent Side Effects Report #5106328-4
Sutent side effect was reported by a Physician from UNITED KINGDOM on Aug 30, 2006. Male patient, 73 years of age, weighting 149.7 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: balance disorder, confusional state, fall
, hallucination, stomatitis. Sutent dosage: 37.5 MG (37.5 MG, DAILY - INTERVAL: CYCLIC); ORAL. During the same period patient was treated with FENTANYL, CIPRALEX, DICLOFENAC, PARACETAMOL, PAMIDRONATE DI, LANSOPRAZOLE, CORSODYL, NYSTATIN. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #5109508-7
Sutent side effect was reported by a Physician from ITALY on Sept 04, 2006. Male patient, 73 years of age, weighting 213.8 lb, was diagnosed with metastatic renal cell carcinoma, mood altered and was treated with Sutent. After drug was administered, patient experienced the following side effects: confusional state, fatigue, haematemesis, hyperbilirubinaemia, mucosal inflammation, thrombocytopenia. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with IPNOVEL, NORVASC, LAMICTAL, CARDIRENE, RYTMONORM, LANSOX, MEDROL ACETATE, PROTIADENE. Patient was hospitalized. Patient died on 09/02/2006.
Sutent Side Effects Report #5113680-2
Sutent side effect was reported by a Physician from UNITED KINGDOM on Sept 07, 2006. Male patient, 73 years of age, weighting 149.7 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: balance disorder, confusional state, fall
, hallucination, stomatitis. Sutent dosage: 37.5 MG (37.5 MG, 1 IN 1D), ORAL. During the same period patient was treated with FENTANYL, CIPRALEX, DICLOFENAC, ACETAMINOPHEN, PAMIDRONATE DI, LANSOPRAZOLE, CORSODYL, NYSTATIN. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #5119953-1
Sutent side effect was reported by a Consumer or non-health professional from NETHERLANDS on Sept 18, 2006. Male patient, 73 years of age, weighting 163.1 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: confusional state, disorientation, fall
, head injury, malaise, pyrexia, renal impairment, thrombocytopenia, vomiting. Sutent dosage: (50 MG, CYCLIC FOR 4WEEKS ON/2 WEEKS OFF), ORAL. During the same period patient was treated with QUINAPRIL, ACENOCOUMAROL. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #5152577-9
Sutent side effect was reported by a Physician from NETHERLANDS on Oct 27, 2006. Male patient, 73 years of age, weighting 163.1 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: confusional state, disorientation, fall
, head injury, malaise, pyrexia, renal impairment, thrombocytopenia, vomiting. Sutent dosage: 50 MG, 1 IN 1 D, ORAL; SEE IMAGE. During the same period patient was treated with QUINAPRIL, ACENOCOUMAROL. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #5177400-8
Sutent side effect was reported by a Physician from ARGENTINA on Dec 01, 2006. Male patient, 73 years of age, weighting 211.6 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: abdominal pain
, adrenal insufficiency, blood chloride decreased, cardio-respiratory arrest, change in sustained attention, confusional state, depressed level of consciousness, mood altered, mucosal inflammation. Sutent dosage: 50 MG (50 MG, QD-EVERY DAY), ORAL. During the same period patient was treated with ENALAPRIL MALEATE, AMLODIPINE, AMIODARONE, ASPIRIN, CARVEDILOL, AMOXICILLIN W, CEFTRIAXONE, HYDROCORTISONE. Patient was hospitalized. Patient died on 11/13/2006.Sutent Side Effects Report #5188713-8
Sutent side effect was reported by a Physician from ARGENTINA on Dec 01, 2006. Male patient, 73 years of age, weighting 211.6 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: abdominal pain
, adrenal insufficiency, anorexia, asthenia, cardio-respiratory arrest, confusional state, disorientation, hyperkalaemia, mood altered. Sutent dosage: 50 MG (50 MG,QD - EVERY DAY), ORAL. During the same period patient was treated with ENALAPRIL MALEATE, AMLODIPINE, AMIODARONE, ASPIRIN, CARVEDILOL, AMOXICILLIN, CEFTRIAXONE, HYDROCORTISONE. Patient was hospitalized. Patient died on 11/13/2006.Sutent Side Effects Report #5763053-4
Sutent side effect was reported by a Physician from GERMANY on May 28, 2008. Male patient, 72 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: blood creatinine increased, confusional state, fatigue, platelet count decreased. Sutent dosage: unknown. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5121448-6
Sutent side effect was reported by a Physician from BRAZIL on Sept 20, 2006. Male patient, 71 years of age, weighting 180.8 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: confusional state. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with PHENYTOIN, TRAMADOL, OMEPRAZOLE, DECADRON. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5131688-8
Sutent side effect was reported by a Physician from BRAZIL on Oct 02, 2006. Male patient, 71 years of age, weighting 180.8 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: confusional state, disease progression, metastases to central nervous system. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with PHENYTOIN, TRAMADOL, OMEPAZOLE, DECADRON. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #4949992-2
Sutent side effect was reported by a Physician from ITALY on Mar 03, 2006. Male patient, 68 years of age, weighting 172.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: asthenia, cerebral ischaemia, confusional state, fibrin d dimer increased, lethargy, platelet count decreased, troponin increased. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with OMEPRAZOLE, LOSARTAN POTASSIUM, METFORMIN, DIAMICRON, ASPIRIN, LORAZEPAM, NADROPARIN CALCIUM, NITROGLYCERIN. Patient was hospitalized. Patient died on 02/05/2006.
Sutent Side Effects Report #4950248-2
Sutent side effect was reported by a Physician from ITALY on Mar 03, 2006. Male patient, 68 years of age, weighting 172.0 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: asthenia, cerebral ischaemia, coagulopathy, confusional state, fibrin d dimer increased, stupor, troponin increased. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with OMEPRAZOLE, LOSARTAN POTASSIUM, METFORMIN, DIAMICRON, ASPIRIN, LORAZEPAM, NADROPARIN CALCIUM, NITROGLYCERIN. Patient was hospitalized. Patient died on 02/05/2006.
Sutent Side Effects Report #5154380-2
Sutent side effect was reported by a Health Professional from BRAZIL on Nov 01, 2006. Male patient, 66 years of age, weighting 152.1 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: anorexia, asthenia, confusional state, disease progression, disorientation, fibrin d dimer increased, leukocytoclastic vasculitis, neurotoxicity. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with SECOTEX, DEXAMETHASONE, CELECOXIB, GLICLAZIDE, FENTANYL, MORPHINE. Patient was hospitalized. Patient died on 04/03/2006.
Sutent Side Effects Report #4931171-6
Sutent side effect was reported by a Health Professional from BRAZIL on Feb 14, 2006. Male patient, 66 years of age, weighting 155.4 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: agitation, anorexia, confusional state, dehydration, diarrhoea, disorientation, fatigue, hypertension, neurotoxicity. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with DEXAMETHASONE, CELECOXIB, TAMSULOSIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #4939516-8
Sutent side effect was reported by a Health Professional from BRAZIL on Feb 22, 2006. Male patient, 66 years of age, weighting 155.4 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: agitation, anorexia, confusional state, dehydration, diarrhoea, disorientation, fatigue, hypertension, neurotoxicity. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with DEXAMETHASONE, CELECOXIB, TAMSULOSIN HYDROCHLORIDE, GLICLAZIDE. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #4941534-0
Sutent side effect was reported by a Physician from SINGAPORE on Feb 23, 2006. Male patient, 66 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: abnormal behaviour, bone erosion, brain oedema, cerebral haemorrhage, confusional state, fall
, feeling abnormal, grand mal convulsion, haemoptysis. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #4950006-9
Sutent side effect was reported by a Health Professional from BRAZIL on Mar 02, 2006. Male patient, 66 years of age, weighting 152.1 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: asthenia, confusional state, disorientation, fibrin d dimer increased, leukocytoclastic vasculitis. Sutent dosage: 50 MG (50 MG, INTERVAL: DAILY), ORAL. During the same period patient was treated with SECOTEX, DEXAMETHASONE, CELECOXIB. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #4954418-9
Sutent side effect was reported by a Health Professional from BRAZIL on Mar 09, 2006. Male patient, 66 years of age, weighting 152.1 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: asthenia, confusional state, disorientation, fibrin d dimer increased, leukocytoclastic vasculitis, neurotoxicity. Sutent dosage: 50 MG (50 MG, INTERVAL: DAILY), ORAL. During the same period patient was treated with SECOTEX, DEXAMETHASONE, CELECOXIB. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #4956344-8
Sutent side effect was reported by a Health Professional from BRAZIL on Mar 10, 2006. Male patient, 66 years of age, weighting 155.4 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: agitation, anorexia, blood electrolytes abnormal, confusional state, dehydration, diarrhoea, disorientation, fatigue, hypertension. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with DEXAMETHASONE, CELECOXIB, TAMSULOSIN HYDROCHLORIDE, GLICLAZIDE. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5018297-6
Sutent side effect was reported by a Health Professional from BRAZIL on May 17, 2006. Male patient, 66 years of age, weighting 152.1 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: asthenia, confusional state, disorientation, fibrin d dimer increased, neurotoxicity, palpable purpura. Sutent dosage: 50 MG (50 MG, INTERVAL: DAILY), ORAL. During the same period patient was treated with SECOTEX, DEXAMETHASONE, CELECOXIB, GLICLAZIDE, FENTANYL, MORPHINE. Patient was hospitalized. Patient died on 04/03/2006.
Sutent Side Effects Report #5018382-9
Sutent side effect was reported by a Health Professional from BRAZIL on May 17, 2006. Male patient, 66 years of age, weighting 155.4 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: agitation, anorexia, confusional state, dehydration, diarrhoea, disorientation, fatigue, hypertension, neurotoxicity. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with DEXAMETHASONE, CELECOXIB, TAMSULOSIN HYDROCHLORIDE, GLICLAZIDE. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5034338-4
Sutent side effect was reported by a Health Professional from SINGAPORE on June 07, 2006. Male patient, 66 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: abnormal behaviour, blood pressure systolic increased, confusional state, convulsion, fall
, feeling abnormal, haemoptysis, heart rate decreased, unresponsive to verbal stimuli. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #5080902-6
Sutent side effect was reported by a Physician from GERMANY on July 28, 2006. Male patient, 65 years of age, weighting 167.6 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: asthenia, cognitive disorder, confusional state, dehydration, pyrexia, thrombocytopenia. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with BISOPROLOL FUMARATE, TILIDINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5100730-2
Sutent side effect was reported by a Health Professional from CANADA on Aug 24, 2006. Male patient, 64 years of age, weighting 231.5 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: confusional state, jaundice
, pulmonary embolism . Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with DECADRON, RANITIDINE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #5120039-0
Sutent side effect was reported by a Health Professional from CANADA on Sept 18, 2006. Male patient, 64 years of age, weighting 231.5 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: confusional state, jaundice
, metastases to central nervous system, pulmonary embolism , therapeutic response unexpected. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with DECADRON, RANITIDINE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #4942853-4
Sutent side effect was reported by a Health Professional from SINGAPORE on Feb 24, 2006. Male patient, 64 years of age, weighting 99.43 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: confusional state. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #4960931-0
Sutent side effect was reported by a Physician from SINGAPORE on Mar 14, 2006. Male patient, 64 years of age, weighting 99.43 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, cerebral infarction, confusional state, metastases to central nervous system. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #4968636-7
Sutent side effect was reported by a Health Professional from CANADA on Mar 22, 2006. Male patient, 64 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: confusional state, jaundice
, metastases to central nervous system, recurrent cancer. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with DECADRON, RANITIDINE, TYLENOL. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #4978908-8
Sutent side effect was reported by a Health Professional from SINGAPORE on Mar 28, 2006. Male patient, 64 years of age, weighting 99.43 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: cerebellar haemorrhage, cerebellar infarction, confusional state, metastases to central nervous system. Sutent dosage: 50 MG (50 MG, 1 IN 1 D),ORAL. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #4960388-X
Sutent side effect was reported by a Physician from SINGAPORE on Mar 14, 2006. Male patient, 63 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: confusional state, dehydration, enteritis. Sutent dosage: 50 MG (50 MG, 1 IN 1 D) ORAL. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5110235-0
Sutent side effect was reported by a Health Professional from IRELAND on Sept 05, 2006. Male patient, 62 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, confusional state, grand mal convulsion. Sutent dosage: 50 MG (50 MG, DAILY - INTERVAL: CYCLIC), ORAL. During the same period patient was treated with DEXAMETHASONE, LANSOPRAZOLE, NYSTATIN, CENTYL K. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5152576-7
Sutent side effect was reported by a Health Professional from IRELAND on Oct 30, 2006. Male patient, 62 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: confusional state, grand mal convulsion, intracranial tumour haemorrhage, metastases to central nervous system. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with DEXAMETHASONE, LANSOPRAZOLE, NYSTATIN, CENTYL K. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5049201-2
Sutent side effect was reported by a Physician from BRAZIL on June 23, 2006. Male patient, 61 years of age, weighting 148.2 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: cachexia, confusional state, dialysis
, hemiparesis, hepatotoxicity, metabolic disorder , opportunistic infection, renal failure acute, respiratory tract infection. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with GLIBENCLAMIDE, ATENOLOL, MINOXIDIL, CALCIUM ACETATE, METFORMIN, ENALAPRIL MALEATE, FUROSEMIDE, IRBESARTAN. Patient was hospitalized and became disabled. Patient recovered.Sutent Side Effects Report #5053667-1
Sutent side effect was reported by a Physician from BRAZIL on June 29, 2006. Male patient, 61 years of age, weighting 148.2 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: cachexia, confusional state, dialysis
, dyspnoea, hemiparesis, hepatotoxicity, intubation complication, metabolic disorder , metastases to central nervous system. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with GLYBURIDE, ATENOLOL, MINOXIDIL, CALCIUM ACETATE, METFORMIN, ENALAPRIL MALEATE, FUROSEMIDE, IRBESARTAN. Patient was hospitalized. Patient died on 06/21/2006.Sutent Side Effects Report #5053964-X
Sutent side effect was reported by a Physician from BRAZIL on June 29, 2006. Male patient, 61 years of age, weighting 148.2 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cachexia, confusional state, dialysis
, dyspnoea, endotracheal intubation complication, hemiparesis, hepatotoxicity. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with GLYBURIDE, ATENOLOL, MINOXIDIL, CALCIUM ACETATE, METFORMIN, ENALAPRIL MALEATE, FUROSEMIDE, IRBESARTAN. Patient was hospitalized. Patient died on 06/21/2006.Sutent Side Effects Report #5159263-X
Sutent side effect was reported by a Physician from BRAZIL on Nov 08, 2006. Male patient, 61 years of age, weighting 148.2 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cachexia, confusional state, delirium, dialysis
, dyspnoea, hemiparesis, hepatotoxicity. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with GLYBURIDE, ATENOLOL, MINOXIDIL, CALCIUM ACETATE, METFORMIN, ENALAPRIL MALEATE, FUROSEMIDE, IRBESARTAN. Patient was hospitalized. Patient died on 06/21/2006.Sutent Side Effects Report #5164785-1
Sutent side effect was reported by a Physician from BRAZIL on Nov 13, 2006. Male patient, 61 years of age, weighting 148.2 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: cachexia, confusional state, delirium, dialysis
, dyspnoea, hemiparesis, hepatotoxicity, ischaemia, opportunistic infection. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with GLYBURIDE, ATENOLOL, MINOXIDIL, CALCIUM ACETATE, METFORMIN, ENALAPRIL MALEATE, FUROSEMIDE, IRBESARTAN. Patient was hospitalized. Patient died on 06/21/2006.Sutent Side Effects Report #5030117-2
Sutent side effect was reported by a Health Professional from BRAZIL on June 01, 2006. Male patient, 61 years of age, weighting 148.2 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, confusional state, dialysis
, dyspnoea, hemiparesis, hepatotoxicity, metabolic disorder , metastases to central nervous system. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with GLYBURIDE, ATENOLOL, MINOXIDIL, CALCIUM ACETATE, METFORMIN, ENALAPRIL MALEATE, FUROSEMIDE, IRBESARTAN. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #5042580-1
Sutent side effect was reported by a Physician from BRAZIL on June 14, 2006. Male patient, 61 years of age, weighting 148.2 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cachexia, confusional state, device related infection, dialysis
, dyspnoea, hemiparesis, hepatotoxicity. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with GLYBURIDE, ATENOLOL, MINOXIDIL, CALCIUM ACETATE, METFORMIN, ENALAPRIL MALEATE, FUROSEMIDE, IRBESARTAN. Patient was hospitalized and became disabled. Patient recovered.Sutent Side Effects Report #5085930-2
Sutent side effect was reported by a Physician from ARGENTINA on Aug 03, 2006. Male patient, 58 years of age, weighting 257.9 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: anal ulcer, bacterial infection
, confusional state, crepitations, escherichia infection, fluid intake reduced, hypotension, hypoxia, metabolic acidosis. Sutent dosage: 50 MG (50 MG, INTERVAL: 4 WEEKS ON 2 OFF). ORAL. During the same period patient was treated with LOSARTAN POTASSIUM, ATENOLOL, ESCITALOPRAM OXALATE, OMEPRAZOLE, DIAZEPAM, DICLOFENAC. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #5093369-9
Sutent side effect was reported by a Physician from ARGENTINA on Aug 16, 2006. Male patient, 58 years of age, weighting 257.9 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: anal ulcer, blood creatinine increased, confusional state, crepitations, escherichia infection, fluid intake reduced, hypoxia, metabolic acidosis, metastases to bone. Sutent dosage: 50 MG (50 MG, FREQUENCY: DAILY INTERVAL: 4 WEEKS ON 2), ORAL. During the same period patient was treated with LOSARTAN POTASSIUM, ATENOLOL, ESCITALOPRAM OXALATE, OMEPRAZOLE, DIAZEPAM, DICLOFENAC. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5043050-7
Sutent side effect was reported by a Physician from ARGENTINA on June 13, 2006. Male patient, 58 years of age, weighting 257.9 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: anal ulcer, bacterial infection
, confusional state, culture positive, escherichia infection, fluid intake reduced, hypotension, necrotising fasciitis, purulent discharge. Sutent dosage: 50 MG (50 MG, INTERVAL: 4 WEEKS ON 2 OFF), ORAL. During the same period patient was treated with LOSARTAN POTASSIUM, ATENOLOL, ESCITALOPRAM, OMEPRAZOLE, DIAZEPAM, DICLOFENAC. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #5082067-3
Sutent side effect was reported by a Physician from BRAZIL on July 31, 2006. Male patient, 56 years of age, weighting 203.5 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: agitation, cardiac arrest
, confusional state, haemorrhoids, neutropenia, rectal haemorrhage, sepsis . Sutent dosage: unknown. During the same period patient was treated with AMLODIPINE, ALLOPURINOL, ASPIRIN, CLOPIDOGREL, ENALAPRIL MALEATE, ISOSORBIDE MONONITRATE, SIMVASTATIN. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #5090881-3
Sutent side effect was reported by a Physician from BRAZIL on Aug 10, 2006. Male patient, 56 years of age, weighting 203.5 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: agitation, anal haemorrhage, cardiac arrest
, confusional state, haemorrhoids, neutropenia, sepsis . Sutent dosage: unknown. During the same period patient was treated with AMLODIPINE, ALLOPURINOL, ASPIRIN, CLOPIDOGREL, ENALAPRIL MALEATE, ISOSORBIDE MONONITRATE, SIMVASTATIN. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #5101324-5
Sutent side effect was reported by a Consumer or non-health professional from BRAZIL on Aug 22, 2006. Male patient, 56 years of age, weighting 203.5 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: agitation, anal haemorrhage, cardiac arrest
, confusional state, depressed level of consciousness, encephalopathy, haemorrhoids, hepatic failure. Sutent dosage: 50 MG (1 IN 1 D), ORAL; SEE IMAGE. During the same period patient was treated with AMLODIPINE, ALLOPURINOL, ASPIRIN, CLOPIDOGREL, ENALAPRIL MALEATE, ISOSORBIDE MONONITRATE, SIMVASTATIN. Patient was hospitalized. Patient died on 08/21/2006.Sutent Side Effects Report #5110919-4
Sutent side effect was reported by a Health Professional from BRAZIL on Sept 06, 2006. Male patient, 56 years of age, weighting 203.5 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: agitation, anal haemorrhage, cardiac arrest
, confusional state, encephalopathy, haemorrhoids, hepatic failure. Sutent dosage: unknown. During the same period patient was treated with AMLODIPINE, ALLOPURINOL, ASPIRIN, CLOPIDOGREL, ENALAPRIL MALEATE, ISOSORBIDE MONONITRATE, SIMVASTATIN. Patient was hospitalized. Patient died on 08/21/2006.Sutent Side Effects Report #5120082-1
Sutent side effect was reported by a Health Professional from BRAZIL on Sept 15, 2006. Male patient, 56 years of age, weighting 203.5 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: agitation, anal haemorrhage, bilirubin conjugated increased, blood bilirubin increased, cardiac arrest
, confusional state, encephalopathy. Sutent dosage: unknown. During the same period patient was treated with AMLODIPINE, ALLOPURINOL, ASPIRIN, CLOPIDOGREL, ENALAPRIL MALEATE, ISOSORBIDE MONONITRATE, SIMVASTATIN. Patient was hospitalized. Patient died on 08/21/2006.Sutent Side Effects Report #5128338-3
Sutent side effect was reported by a Health Professional from BRAZIL on Sept 28, 2006. Male patient, 56 years of age, weighting 203.5 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: agitation, anal haemorrhage, cardiac arrest
, condition aggravated, confusional state, depressed level of consciousness, encephalopathy. Sutent dosage: 50 MG (1 IN 1 D), ORAL; 37.5 MG (12.5 MG, 3 IN 1 D), ORAL. During the same period patient was treated with AMLODIPINE, ALLOPURINOL, ASPIRIN, CLOPIDOGREL, ENALAPRIL MALEATE, ISOSORBIDE MONONITRATE, SIMVASTATIN. Patient was hospitalized. Patient died on 08/21/2006.Sutent Side Effects Report #5187079-7
Sutent side effect was reported by a Health Professional from BRAZIL on Dec 01, 2006. Male patient, 56 years of age, weighting 203.5 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: agitation, bacterial infection
, cardiac arrest , confusional state, depressed level of consciousness, encephalopathy, hepatic failure. Sutent dosage: unknown. During the same period patient was treated with AMLODIPINE, ALLOPURINOL, ASPIRIN, CLOPIDOGREL, ENALAPRIL MALEATE, ISOSORBIDE MONONITRATE, SIMVASTATIN, OMEPRAZOLE. Patient was hospitalized. Patient died on 08/21/2006.Sutent Side Effects Report #5118141-2
Sutent side effect was reported by a Physician from BRAZIL on Sept 13, 2006. Female patient, 55 years of age, weighting 121.3 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: confusional state, depression
, mood altered. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with OMEPRAZOLE, GABAPENTIN, BROMAZEPAM, MORPHINE. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #5128322-X
Sutent side effect was reported by a Physician from BRAZIL on Sept 28, 2006. Female patient, 55 years of age, weighting 121.3 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: confusional state, depression
, mood altered. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with OMEPRAZOLE, GABAPENTIN, BROMAZEPAM, MORPHINE. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #5186340-X
Sutent side effect was reported by a Physician from BRAZIL on Nov 30, 2006. Female patient, 55 years of age, weighting 121.3 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: confusional state, mood altered, neurological symptom. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with OMEPRAZOLE, GABAPENTIN, BROMAZEPAM, MORPHINE. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5033375-3
Sutent side effect was reported by a Physician from AUSTRALIA on June 07, 2006. Female patient, 47 years of age, weighting 121.9 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: ammonia increased, aphagia, biliary sepsis, confusional state, depressed level of consciousness, disseminated intravascular coagulation, hepatic failure, incontinence. Sutent dosage: 50 MG (50 MG, FOR 28 DAYS), ORAL. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5133135-9
Sutent side effect was reported by a Physician from KOREA, REPUBLIC OF on Oct 04, 2006. Male patient, 40 years of age, weighting 115.7 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: catheter related complication, condition aggravated, confusional state, depressed level of consciousness, dyspnoea, iatrogenic injury, incoherent, pleural effusion, pneumothorax. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5151873-9
Sutent side effect was reported by a Physician from KOREA, REPUBLIC OF on Oct 27, 2006. Male patient, 40 years of age, weighting 115.7 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: ascites, confusional state, disease progression, dyspnoea, incoherent, pleural effusion, pneumothorax, renal failure acute. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. Patient was hospitalized. Patient died on 10/27/2006.
Sutent Side Effects Report #5479991-6
Sutent side effect was reported by a Physician from GERMANY on Sept 26, 2007. Female patient, weighting 165.3 lb, was diagnosed with metastatic renal cell carcinoma, hypertension and was treated with Sutent. After drug was administered, patient experienced the following side effects: aphasia
, asthenia, blood bilirubin increased, blood creatine phosphokinase increased, blood creatinine increased, cholestasis, confusional state, dehydration, depressed level of consciousness. Sutent dosage: DAILY DOSE:50MG. During the same period patient was treated with HYDROCHLOROTHIAZIDE, RAMIPRIL, ACE INHIBITOR NOS, BAYOTENSIN, NORVASC. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #5624950-3
Sutent side effect was reported by a Physician from GERMANY on Feb 02, 2008. Male patient was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: confusional state, dysarthria, gait disturbance. Sutent dosage: DAILY DOSE:50MG. During the same period patient was treated with ALLOPURINOL, SEVREDOL, MACROGOL, METAMIZOLE, MORPHINE, NOVALGIN, MARCUMAR. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5639372-9
Sutent side effect was reported by a Physician from GERMANY on Feb 14, 2008. Male patient was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: confusional state, dysarthria, gait disturbance. Sutent dosage: DAILY DOSE:50MG. During the same period patient was treated with ALLOPURINOL, SEVREDOL, MACROGOL, ENALAPRIL MALEATE, METAMIZOLE, MORPHINE, NOVALGIN, MARCUMAR. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5660927-X
Sutent side effect was reported by a Physician from GERMANY on Feb 29, 2008. Male patient was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: confusional state, dysarthria, gait disturbance. Sutent dosage: DAILY DOSE:50MG. During the same period patient was treated with ALLOPURINOL, SEVREDOL, MACROGOL, ENALAPRIL MALEATE, METAMIZOLE, MORPHINE, NOVALGIN. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5676301-6
Sutent side effect was reported by a Consumer or non-health professional from GERMANY on Feb 29, 2008. Male patient was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: confusional state, dysarthria, gait disturbance. Sutent dosage: DAILY DOSE:50MG. During the same period patient was treated with ALLOPURINOL, SEVREDOL, MACROGOL, ENALAPRIL MALEATE, METAMIZOLE, MORPHINE, NOVALGIN. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5715301-4
Sutent side effect was reported by a Physician from UNITED STATES on Apr 11, 2008. Female patient, weighting 117.9 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: amnesia, confusional state, dizziness
, gait disturbance, haemolysis, lethargy, metabolic function test abnormal, oral discomfort, oral intake reduced. Sutent dosage: unknown. During the same period patient was treated with CELEXA, SYNTHROID, PREMARIN, FOSAMAX, FOLIC ACID, ALLOPURINOL, VITAMIN CAP. Patient was hospitalized. Patient died on 01/01/2008.Sutent Side Effects Report #5740851-4
Sutent side effect was reported by a Physician from UNITED STATES on May 06, 2008. Female patient, weighting 134.5 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: blood glucose increased, confusional state, decreased appetite, dehydration, diarrhoea, disease progression, fatigue, gastroenteritis
, hypoglycaemic coma. Sutent dosage: unknown. During the same period patient was treated with FERROUS SULPHATE, VALIUM, NORCO, WARFARIN, MEVACOR, ALLEGRA D, PLAVIX, IMDUR. Patient was hospitalized. Patient died on 02/01/2008.Sutent Side Effects Report #5782266-9
Sutent side effect was reported by a Physician from UNITED STATES on June 11, 2008. Female patient, weighting 117.9 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: amnesia, confusional state, dizziness
, gait disturbance, haemolysis, lethargy, metabolic function test abnormal, oral discomfort, oral intake reduced. Sutent dosage: unknown. During the same period patient was treated with CELEXA, SYNTHROID, PREMARIN, FOSAMAX, FOLIC ACID, ALLOPURINOL, VITAMIN CAP. Patient was hospitalized. Patient died on 01/01/2008.Sutent Side Effects Report #5829571-5
Sutent side effect was reported by a Physician from UNITED STATES on July 22, 2008. Female patient, weighting 116.8 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: amnesia, confusional state, dizziness
, dysgeusia, gait disturbance, haemolysis, headache , hypophagia, lethargy. Sutent dosage: unknown. During the same period patient was treated with CELEXA, EFFEXOR, SYNTHROID, PREMARIN, FOSAMAX, FOLIC ACID, ALLOPURINOL. Patient was hospitalized. Patient died on 01/01/2008.Sutent Side Effects Report #5891639-5
Sutent side effect was reported by a Health Professional from UNITED STATES on Sept 15, 2008. Female patient, weighting 134.5 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: blood glucose increased, confusional state, decreased appetite, dehydration, diarrhoea, disease progression, fatigue, gastroenteritis
, hypoglycaemic coma. Sutent dosage: unknown. During the same period patient was treated with FERROUS SULPHATE, VALIUM, NORCO, WARFARIN, MEVACOR, ALLEGRA, PLAVIX, IMDUR. Patient was hospitalized. Patient died on 02/01/2008.Sutent Side Effects Report #5939222-7
Sutent side effect was reported by a Physician from UNITED STATES on Oct 22, 2008. Female patient, weighting 116.8 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: amnesia, confusional state, dizziness
, dysgeusia, gait disturbance, haemolysis, headache , hypophagia, lethargy. Sutent dosage: unknown. During the same period patient was treated with CELEXA, EFFEXOR, SYNTHROID, PREMARIN, FOSAMAX, FOLIC ACID, ALLOPURINOL. Patient was hospitalized. Patient died on 01/01/2008.Sutent Side Effects Report #5953825-5
Sutent side effect was reported by a Physician from UNITED STATES on Nov 10, 2008. Female patient, weighting 116.8 lb, was diagnosed with metastatic renal cell carcinoma and was treated with Sutent. After drug was administered, patient experienced the following side effects: amnesia, confusional state, dizziness
, dysgeusia, enterococcal infection, escherichia infection, gait disturbance, haemolysis, headache . Sutent dosage: unknown. During the same period patient was treated with CELEXA, EFFEXOR, SYNTHROID, PREMARIN, FOSAMAX, FOLIC ACID, ALLOPURINOL. Patient was hospitalized. Patient died on 01/01/2008.Sutent Side Effects Report #5161616-0
Sutent side effect was reported by a Physician from NORWAY on Nov 06, 2006. Male patient, 74 years of age, was diagnosed with metastases to liver and was treated with Sutent. After drug was administered, patient experienced the following side effects: asthenia, atelectasis, blood creatinine increased, blood potassium increased, c-reactive protein increased, confusional state, dysarthria, extensor plantar response, gait disturbance. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with PARAFFIN, DURAGESIC, ACETAMINOPHEN, MEDROL, ZOFRAN, LAXOBERAL, ZOPICLONE. Patient was hospitalized. Patient died on 09/24/2006.
Sutent Side Effects Report #5087009-2
Sutent side effect was reported by a Health Professional from AUSTRALIA on Aug 07, 2006. Male patient, 67 years of age, weighting 149.0 lb, was diagnosed with mesothelioma
and was treated with Sutent. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine decreased, blood sodium decreased, blood urea increased, confusional state, convulsion, dehydration. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with AVAPRO HCT, ACYCLOVIR, DEXAMETHASONE, METOCLOPRAMIDE, MS CONTIN, MYLANTA. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #6028459-7
Sutent side effect was reported by a Health Professional from UNITED STATES on Dec 04, 2008. Female patient was diagnosed with meningioma and was treated with Sutent. After drug was administered, patient experienced the following side effects: confusional state, gait disturbance, muscular weakness, proteinuria. Sutent dosage: unknown. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #6086731-9
Sutent side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 10, 2009. Female patient, weighting 145.1 lb, was diagnosed with hepatic neoplasm malignant non-resectable and was treated with Sutent. After drug was administered, patient experienced the following side effects: confusional state, dehydration, fatigue. Sutent dosage: 37.5 MG, 1X/DAY. During the same period patient was treated with DOXORUBICIN. Patient recovered.
Sutent Side Effects Report #6113169-8
Sutent side effect was reported by a Health Professional from UNITED STATES on Mar 02, 2009. Female patient, weighting 145.1 lb, was diagnosed with hepatic neoplasm malignant non-resectable and was treated with Sutent. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood potassium decreased, cholangitis, confusional state, dehydration, fatigue, sepsis
. Sutent dosage: 37.5 MG, 1X/DAY. During the same period patient was treated with DOXORUBICIN, OXYCODONE, LACTULOSE. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #5049088-8
Sutent side effect was reported by a Physician from FRANCE on June 23, 2006. Male patient, 70 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Sutent. After drug was administered, patient experienced the following side effects: asthenia, cerebrovascular accident, confusional state, epistaxis, mucosal inflammation, nasopharyngitis, somnolence, thrombocytopenia. Sutent dosage: 50 MG (50 MG,4 WEEKS INTERVAL: 7 WEEKS), ORAL. During the same period patient was treated with ZOCOR, CERVOXAN, GINKOR, XANAX, PRAVASTATIN, AUGMENTIN, CELESTONE, NEXIUM. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5070331-3
Sutent side effect was reported by a Physician from FRANCE on July 18, 2006. Male patient, 70 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Sutent. After drug was administered, patient experienced the following side effects: asthenia, brain scan abnormal, cerebrovascular accident, confusional state, epistaxis, infection
, mucosal inflammation, nasopharyngeal disorder, somnolence. Sutent dosage: 50 MG (50 MG, 4 WEEK INTERVAL: 7 WEEKS) ORAL. During the same period patient was treated with ZOCOR, CERVOXAN, GINKOR, XANAX, PRAVASTATIN, AUGMENTIN, CELESTONE, NEXIUM. Patient was hospitalized. Patient recovered.Sutent Side Effects Report #5139517-3
Sutent side effect was reported by a Physician from FRANCE on Oct 11, 2006. Male patient, 70 years of age, was diagnosed with hepatic neoplasm malignant and was treated with Sutent. After drug was administered, patient experienced the following side effects: asthenia, cerebrovascular accident, confusional state, epistaxis, nasopharyngitis, somnolence, thrombocytopenia. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with ZOCOR, CERVOXAN, GINKOR, XANAX, PRAVASTATIN, AUGMENTIN, CELESTONE, NEXIUM. Patient was hospitalized. Patient recovered.
Sutent Side Effects Report #5022181-1
Sutent side effect was reported by a Physician from FRANCE on May 23, 2006. Male patient, 65 years of age, weighting 198.4 lb, was diagnosed with hepatic neoplasm malignant and was treated with Sutent. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, confusional state, gamma-glutamyltransferase increased, hyperbilirubinaemia, somnolence, thrombocytopenia. Sutent dosage: 50 MG (50 MG, 1 IN 1 D), ORAL. During the same period patient was treated with PROPRANOLOL. Patient was hospitalized. Patient recovered.